Form 8-K - Current report:
SEC Accession No. 0000875045-21-000018
Filing Date
2021-04-09
Accepted
2021-04-09 16:33:53
Documents
17
Period of Report
2021-04-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20210407.htm   iXBRL 8-K 34037
2 EX-99.1 exhibit991-directoreventpr.htm EX-99.1 21777
8 biogenlogostandarda291.jpg GRAPHIC 756402
9 picture21.jpg GRAPHIC 12959
  Complete submission text file 0000875045-21-000018.txt   1245102

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20210407.xsd EX-101.SCH 2443
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20210407_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20210407_def.xml EX-101.DEF 1663
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20210407_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20210407_pre.xml EX-101.PRE 12662
10 EXTRACTED XBRL INSTANCE DOCUMENT biib-20210407_htm.xml XML 10508
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 21818220
SIC: 2836 Biological Products, (No Diagnostic Substances)